https://de.marketscreener.com/kurs/aktie/ROCHE-HOLDING-AG-68997/news/Roche-erhalt-Zulassung-von-Swissmedic-fur-Krebsmittel-Gavreto-36688401/?utm_source=telegram&utm_medium=social&utm_campaign=share